Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with &ldquo;Hit and Run&rdquo; Tumor Delivery to Eradicate Gastric Cancer (Adv. Therap. 3/2023)

Zhang Li; AragonSanabria Virginia; Aditya Anusha; Marelli Marcello; Cao Tianye; Chen Feng; Yoo Barney; Ma Kai; Zhuang Li; Cailleau Thais; Masterson Luke; Turker Melik Z.; Lee Rachel; DeLeon Gabriel; Monette Sebastien; Colombo Raffaele; Christie Ronald J.; Zanzonico Pat; Wiesner Ulrich; Subramony J. Anand; Bradbury Michelle S.

doi:10.1002/ADTP.202370009

赞收藏引用

科研之友

微信

新浪微博

Facebook

分享链接

Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer (Adv. Therap. 3/2023)

作者：Zhang Li; AragonSanabria Virginia; Aditya Anusha; Marelli Marcello; Cao Tianye; Chen Feng; Yoo Barney; Ma Kai; Zhuang Li; Cailleau Thais; Masterson Luke; Turker Melik Z.; Lee Rachel; DeLeon Gabriel; Monette Sebastien; Colombo Raffaele; Christie Ronald J.; Zanzonico Pat; Wiesner Ulrich; Subramony J. Anand; Bradbury Michelle S.

来源：Advanced Therapeutics, 2023, 6(3).

DOI：10.1002/ADTP.202370009

HER2 targeted
gastric cancer
nanoparticle drug-immune conjugate
silica
therapy
topoisomerase inhibitor
ultrasmall

全文

访问全文

收藏分享被引浏览

更新时间：2024-01-10 04:23

相似论文
引用论文
参考文献

Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer (Adv. Therap. 3/2023)

全文

产品服务

站内浏览

服务支持

联系方式

科研之友